Discontinuation of Antimicrobial Prophylaxis (AP) in Children With Spina Bifida: A Case Series Analysis

Kevin G Couloures1, Michael Anderson2, Michael Machiorlatti2

  • 1Yale School of Medicine, New Haven, Connecticut, USA.

Nephro-Urology Monthly
|November 24, 2016
PubMed

Insights

Selective Treatment (ST) using catheterization and bowel management significantly reduced urinary tract infections (UTIs) in children with spina bifida, decreasing the need for antimicrobial prophylaxis (AP) and improving renal function.

Area of Science:

  • Pediatric Nephrology
  • Urology
  • Infectious Diseases

Background:

  • Spina bifida patients have a high risk of urinary tract infections (UTIs).
  • Antimicrobial prophylaxis (AP) can reduce symptomatic UTIs but promotes antimicrobial resistance.
  • Bladder emptying and constipation management are alternative UTI prevention strategies.

Purpose of the Study:

  • To evaluate if a Selective Treatment (ST) regimen, emphasizing catheterization and bowel management, can reduce the need for AP in children with spina bifida.
  • To assess the impact of ST on UTI incidence and renal function compared to AP.

Main Methods:

  • A case series analysis of 67 pediatric spina bifida patients was conducted.
  • Routine AP was replaced with clean-catch catheterization and a daily bowel regimen (ST).
  • UTI incidence, renal function (creatinine clearance/GFR), and antibiotic resistance patterns were retrospectively reviewed.

Main Results:

  • The mean number of UTIs decreased from 8.7 on AP to 1.0 on ST.
  • No infections on ST required intravenous antibiotics due to resistance, unlike 5 infections on AP.
  • A significant improvement in Glomerular Filtration Rate (GFR) was observed when switching from AP to ST.

Conclusions:

  • Antimicrobial prophylaxis (AP) is ineffective in preventing UTIs in spina bifida patients and contributes to resistant organisms.
  • Discontinuing AP and adhering to a catheterization regimen (ST) improved susceptibility to oral antimicrobials and preserved renal function.
  • Selective Treatment (ST) with catheterization and bowel management is a viable alternative to AP for UTI prevention and renal protection in spina bifida.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
346
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
605
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
235
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
660
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
380
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306